Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
7 hedge funds and large institutions have $5.03M invested in Forward Pharma A/S American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
17% more funds holding
Funds holding: 6 → 7 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
34% less capital invested
Capital invested by funds: $7.64M → $5.03M (-$2.61M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$399K |
| 2 |
Renaissance Technologies
New York
|
+$217K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$103K |
| 4 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$64.2K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$9.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
-$1.98M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$1.78M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.03K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$6K |
FWP Hedge Fund Activity: Q2 2020 in Review
7 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q2 2020, worth a combined $5.03M — down 34% from $7.64M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FWP positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $399K. The largest seller was Newtyn Management, exiting entirely with an estimated $1.98M sold.
- 7 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q2 2020, up from 6 in Q1 2020.
- Funds reported $5.03M of Forward Pharma A/S American Depositary Shares stock for Q2 2020, down 34% quarter-over-quarter.
- 3 funds opened new Forward Pharma A/S American Depositary Shares positions in Q2 2020 and 2 closed out, a net change of +1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q2 2020 was Morgan Stanley, an estimated $399K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q2 2020 was Newtyn Management, an estimated $1.98M sold.
Based on aggregated 13F filings for Q2 2020.